US FDA declines to approve AbbVie's Parkinson's disease therapy – Reuters

  1. The US FDA refuses to approve AbbVie’s Parkinson’s disease therapy.Reuters
  2. FDA slams Abivin’s blockbuster-to-be Parkinson’s drugFiercePharma
  3. AbbVie submits regulatory update on Parkinson’s disease drug candidateYahoo Finance
  4. ABBV (NYSE: ABBV) stock drops as FDA rejects Parkinson’s treatmentSeeking Alpha
  5. FDA rejects approval of AbbVie’s Parkinson’s therapyNewsmax
  6. See full coverage on Google News


Leave a Reply

Your email address will not be published. Required fields are marked *